Evaluation of Efficacy and Safety of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control With Diet and Exercise Alone
Clinical trial NCT01257412 · SUSPENDED
Trial details
- NCT number
- NCT01257412
- Sponsor
- AstraZeneca
- Status
- SUSPENDED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2013-06-01
- Enrollment
- 375
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.